Sequencing by Expansion - Meet the future of NGS

* Advertisement - in cooperation with Roche *

The next frontier of NGS is moving beyond traditional DNA sequencing technologies toward Sequencing by Expansion (SBX). By converting native DNA into a "surrogate" polymer called an Xpandomer, this technology overcomes the physical density of genetic material. Through precise molecular engineering, reporter codes are expanded to over 50 times the length of typical bases, dramatically improving signal resolution and reading speed.

This innovation utilizes highly engineered X-NTP building blocks and a specialized polymerase to synthesize the Xpandomer, ensuring robust, high-accuracy reads with flexible lengths. The process culminates in a CMOS-based sensor array that drives single-molecule measurement at incredible speeds, bypassing the delays of traditional cycle-based sequencing techniques. With the ability to move from sample to results in under four hours and a reusable sensor design that slashes costs, SBX is set to redefine clinical research.

Join us for an exclusive look

Curious to see how sequencing by expansion is redefining the limits of speed and accuracy in clinical research? We invite you to join our upcoming Luncheon on April 21st, 11.40 - 12.10 h where Dr. Gregor Obernosterer, Roche Diagnostics, will dive deeper into technology behind the SBX platform.

Click here for further details.

Veröffentlicht: 26.03.2026